Results 111 to 120 of about 1,823 (190)

N- and O‑Prenylated Quinolones: Syntheses and <i>In Vitro</i> and <i>In Vivo</i> Antischistosomal Evaluation. [PDF]

ACS Med Chem Lett
Khethang K, Häberli C, Dube PS, Legoabe LJ, Keiser J, Beteck RM.   +5 more
europepmc   +1 more source

Elexacaftor-Tezacaftor-Ivacaftor Reduces Revision Sinus Surgery in People With Cystic Fibrosis. [PDF]

Laryngoscope
Lin A, Komara M, Kistler I, Tan ZH, Lind M, Kotha K, Chiang T.   +6 more
europepmc   +1 more source

Ivacaftor-tezacaftor-elexacaftor, tezacaftor-ivacaftor and lumacaftor-ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation.

Health Technol Assess
Edwards SJ, Farrar BG, Ennis K, Downes N, Wakefield V, Mackenzie I, Walters A, Jhita T.   +7 more
europepmc   +1 more source

Impact of CFTR modulator concentrations on clinical response in cystic fibrosis. [PDF]

Eur Respir J
Chalamalla AR, Baker E, Ryan KJ, Dowell A, Natt JR, Zemanick ET, Konstan MW, Mayer-Hamblett N, Acosta EP, Guimbellot JS, CHEC-SC investigators.   +10 more
europepmc   +1 more source

Biocatalytic Generation of o-Quinone Imines in the Synthesis of 1,4-Benzoxazines and Its Comparative Green Chemistry Metrics. [PDF]

ACS Sustain Chem Eng
Tehami M, Imam HT, Abdullah I, Hosford J, Wong XJ, Rahman NA, Wong LS.   +6 more
europepmc   +1 more source

Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. [PDF]

J Cyst Fibros
Sinkey RG, Garcia B, Fowler CM, Krick S, Ryan KJ, Acosta EP, Guimbellot JS.   +6 more
europepmc   +1 more source

Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic Fibrosis. [PDF]

Int J Mol Sci
Castaldo A, Cuomo M, Iacotucci P, Carnovale V, Chiariotti L, Castaldo G, Gelzo M.   +6 more
europepmc   +1 more source

Ivacaftor affects the susceptibility of standard-of-care drugs used to treat <i>Mycobacterium abscessus</i> lung disease. [PDF]

Antimicrob Agents Chemother
Shrivastava A, Singh S, Boorgula GD, Galvez R-A, Srivastava S.   +4 more
europepmc   +1 more source

Theratyping as a tool to guide clinical decision-making in patients with suspected cystic fibrosis and variants currently ineligible for CFTR modulator therapy. [PDF]

Respir Med
Gannon RM, Wright BA, Bettis BA, Teresi ME, Fischer AJ, Weiner RL, Peña T, Hornick DB, Thornell IM, Rehman T, Pezzulo AA.   +10 more
europepmc   +1 more source

A Broadly Applicable Strategy to Aminate Azines Enabled by Electronically Tuned Phosphine Reagents. [PDF]

Angew Chem Int Ed Engl
Liu RR, Levy JN, McNally A.
europepmc   +1 more source